Dr. Falk Pharma GmbH

DEB8536.HRB3266|Leinenweberstr. 5, 79108 Freiburg im BreisgauGermany|1987

Profit€76.2M

Revenue€497.4M

Employees1.3K

Balance€829.3M

About

Hersteller und Vertrieb von pharmazeutischen und diagnostischen Präparaten mit Fokus auf Gastroenterologie und Hepatologie.

Business purpose (commercial register)

Die Herstellung und der Vertrieb von pharmazeutischen und diagnostischen Präparaten.

ClassificationWZ 2025

No. 219 of 1,387 – Top Employers with 1,000+ Staff C.21.20.0 - Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen C.21.10.0 - Herstellung von pharmazeutischen Grundstoffen

Network

CompanyPersonShareholdingOfficer or Prokura

Business Sectors

Pharmazeutika391.428 TEUR(99.5%)

Lizenzerloese1.777 TEUR(0.5%)

Products

Arzneimittel Diagnostika Wirkstoffe

Opportunities & Risks

Internationalisierung Forschung Innovation Zukauf Wachstum Diagnostik

Regulierung Arzneimittel Geopolitische Risiken Lieferketten Patente Preisdruck Wettbewerbsdruck

This summary was generated with the help of AI. See our Data Quality Notice. Report error?

Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 3266 (as of 20 October 2026)

Company Structure

Shareholders

Name	Type	City
Philipp Argast	Geschäftsführer(in)	Freiburg im Breisgau
Kai Pinkernell	Geschäftsführer(in)	Lindlar
Stephanie Striegler	Geschäftsführer(in)	Lörrach
Torben Zachmann	Geschäftsführer(in)	Weßling

Company	Location
Losan Pharma GmbH	Neuenburg am Rhein

Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 3266 (as of 20 October 2026)

Company History

Management

Date	Event Type	Event
30.04.2019	Gesellschaftsvertrag amended	Gesellschaftsvertrag
04.04.2018	Gesellschaftsvertrag amended	Gesellschaftsvertrag
15.01.2009	Business Address Registered	Leinenweberstr. 5, 79108 Freiburg im Breisgau

Date	Type	Change	Total Capital
16.03.2006	Share Capital Set	—	800.000 €

CPV categories

Pharmaceutical products

Date	Contract	Role	Counterparty	Value
20.10.2026	Vergaben von Arzneimitteln und apothekenüblichen Produkten zum 01.01.2027 und 01.07.2027 Supplier · PBMG eG	Supplier	PBMG eG	—

Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 3266 (as of 20 October 2026)

Financials

Key financial figures over time — Dr. Falk Pharma GmbH
Year	Revenue	Profit	Balance	Employees
2024	€497,397,189	€76,157,893	€829,336,547	1,346
2023	€499,352,331	€71,754,807	€770,373,917	1,198
2022	€521,301,265	€91,614,583	€710,012,052	1,048
2021	€486,946,608	€84,770,526	€610,089,813	967
2020	€437,991,739	€84,229,582	€499,463,786	897
2019	€438,220,389	€87,892,204	€432,671,260	840
2018	€424,209,243	€98,698,612	€625,782,740	775
2017	€382,676,081	€80,852,917	€535,166,537	682
2016	€355,787,039	€91,670,099	€479,324,739	629
2015	€345,159,362	€91,378,418	€397,393,948	—

Source: German Company Register (Unternehmensregister)

Register Files

Current Printout (AD)

Chronological Printout (CD)

List of ShareholdersPublished on 14 January 2020

Articles of AssociationPublished on 22 March 2019

Registration ApplicationPublished on 11 June 2026

Source: German Commercial Register (Handelsregister) Freiburg Local Court, HRB 3266 (as of 20 October 2026)

Contact

Website:drfalkpharma.com

Email:Sign in to view

USt-IdNr.:DE142104856

Similar Companies

Haleon Germany GmbH

München · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen

€561.0M

Omnicare Beteiligungen GmbH

Unterföhring · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen

€608.3M

Klosterfrau Deutschland GmbH

Köln · Herstellung von pharmazeutischen Spezialitäten und sonstigen pharmazeutischen Erzeugnissen

€459.5M

Annual Financial Statements

Annual Report 2024Published on 30 September 2025

Consolidated Report 2024Published on 9 September 2025

Annual Report 2023Published on 12 November 2024

Consolidated Report 2023Published on 31 October 2024

Annual Report 2022Published on 12 January 2024

Consolidated Report 2022Published on 19 December 2023

Annual Report 2021Published on 16 May 2023

Consolidated Report 2021Published on 25 April 2023

Annual Report 2020Published on 31 March 2022

Consolidated Report 2020Published on 19 January 2022

Annual Report 2019Published on 3 March 2021

Consolidated Report 2019Published on 12 February 2021

Annual Report 2018Published on 6 March 2020

Consolidated Report 2018Published on 4 February 2020

Consolidated Report 2017Published on 4 February 2020

Annual Report 2017Published on 15 March 2019

Consolidated Report 2016Published on 4 February 2020

Annual Report 2016Published on 13 March 2018

Consolidated Report 2015Published on 13 June 2017

Annual Report 2015Published on 9 February 2017

Consolidated Report 2014Published on 27 July 2017

Annual Report 2014Published on 17 March 2016

Annual Report 2013Published on 26 March 2015

Consolidated Report 2012Published on 27 July 2017

Annual Report 2012Published on 13 May 2014

Annual Report 2011Published on 8 March 2013

Annual Report 2010Published on 10 February 2012

Annual Report 2009Published on 8 February 2011

Annual Report 2008Published on 26 February 2010

Annual Report 2007Published on 17 February 2009

Annual Report 2005Published on 24 January 2007

Source: German Company Register (Unternehmensregister)

Cost type	Amount	Share
Personnel Costs	€107,360,232	40.9%
Material Costs	€142,602,519	54.3%
Depreciation	€12,465,571	4.7%
Interest & Similar	€295,856	0.1%

Dr. Falk Pharma GmbH

About

Business purpose (commercial register)

ClassificationWZ 2025

Network

Business Sectors

Products

Opportunities & Risks

Company Structure

Company History

Financials

Register Files

Contact

Similar Companies

Annual Financial Statements

Cost Distribution (2024)